EU MDR Technical Documentation Consulting Services

EU MDR technical documentation is the structured evidence package required to demonstrate that a medical device complies with Regulation (EU) 2017/745. It typically includes device description, design and manufacturing information, GSPR evidence, risk management, verification and validation data, clinical evaluation, labeling, and post-market documentation. It must be organized clearly for Notified Body review.

A compliant technical file should include the elements required under EU MDR Annex II and Annex III. That generally means device description and specification, intended purpose, design and manufacturing details, applicable standards, GSPR checklist, risk management file, test and validation reports, clinical evaluation, labeling and IFU, PMS documentation, and traceable supporting evidence throughout.

EU MDR requires broader, deeper, and more traceable documentation than legacy MDD. Notified Bodies now expect stronger clinical evidence, tighter linkage between risk management and GSPRs, more robust post-market documentation, and clearer justification for safety and performance claims. Many legacy files fail because they are incomplete, poorly cross-referenced, or not updated to current MDR expectations.

Yes. Elexes supports both Annex II technical documentation and Annex III post-market technical documentation. That includes structuring the file, drafting or reviewing sections, identifying missing evidence, improving traceability, and aligning supporting records such as CERs, PMS plans, PMCF outputs, risk files, labeling, and performance data into one coherent submission package.

Yes. Elexes offers readiness and gap assessments to evaluate your current documentation against EU MDR requirements and likely Notified Body expectations. The review covers completeness, consistency, evidence quality, and cross-referencing. You receive a prioritized remediation plan so your team can address high-risk deficiencies before formal submission and reduce avoidable review delays.

Yes. Elexes develops and reviews device-specific GSPR checklists that map each applicable requirement to the exact evidence of conformity, such as harmonized standards, test reports, clinical data, labeling, and risk management outputs. The goal is to create a complete, traceable matrix that is easy for reviewers to follow and defend during audit or submission review.

Yes. Elexes provides hands-on remediation support for weak or incomplete risk management files, CERs, PMCF documentation, labeling, and related technical file sections. The team identifies the regulatory basis for each gap, prioritizes remediation by severity, and helps rebuild documentation so it aligns with EU MDR expectations and supports a defensible compliance narrative.

This service is valuable for startups preparing first submissions, manufacturers transitioning from MDD, companies responding to Notified Body feedback, and teams managing significant device changes. It is especially useful when internal RAQA resources are limited, documentation has grown inconsistent over time, or the organization needs expert support to accelerate CE marking without compromising compliance quality.